Common Back-Pain Drug May Be Linked to Higher Dementia Risk, Large Study Finds

📉 Key Findings:

Group

Increased Risk

All adults taking ≥6 prescriptions

âž• 29% higher risk of dementia<br>âž• 85% higher risk of mild cognitive impairment (MCI) within 10 years

Adults aged 35–49

🔺 More than double the risk of dementia<br>🔺 Over triple the risk of MCI

Adults aged 50–64

Significantly elevated risk — nearly matching younger group

Adults 18–34

No significant increase found

👉 The longer and more frequently people used gabapentin, the greater the cognitive risk.

And shockingly, the highest dangers weren’t in older adults—but in those in their 30s, 40s, and 50s, who are decades away from typical dementia onset.

💊 What Is Gabapentin?

Originally developed as an anti-seizure medication, gabapentin (brand names Neurontin, Gralise, Horizant) is now widely prescribed off-label for:

Chronic back and nerve pain

Sciatica

Fibromyalgia

Restless leg syndrome

Anxiety and sleep issues (though not FDA-approved for these)

Why it’s popular:

Not addictive like opioids

Often covered by insurance

Generally well-tolerated short-term

But this new research suggests that long-term use may come with hidden neurological costs.

🧠 Why Might Gabapentin Affect the Brain?

While the exact mechanism isn’t fully understood, experts believe several factors may play a role: